Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06339034
PHASE1/PHASE2
Repurposing Lithium for Parkinson's Disease: a RCT
Sponsor: State University of New York at Buffalo
View on ClinicalTrials.gov
Summary
This study will examine the effects of lithium 20mg/day compared to placebo on MRI and blood-based biomarkers among 20 early-stage Parkinson's disease patients.
Official title: Repurposing Lithium as a Disease-modifying Therapy in Parkinson's Disease: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
40 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2024-07-03
Completion Date
2026-02
Last Updated
2025-07-08
Healthy Volunteers
No
Conditions
Interventions
DIETARY_SUPPLEMENT
Lithium
5mg of elemental lithium/capsule
OTHER
Placebo
Cellulose-filled capsules
Locations (1)
UBMD Neurology
Williamsville, New York, United States